Pharma Journalist -

Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production…
Read More...

Valneva SE and Pfizer Inc. announced the closing of the equity investment announced on June 20, 2022. Pursuant to an Equity Subscription Agreement, Pfizer has invested €90.5 ($95)…
Read More...

Novartis announced that the European Commission (EC) approved Tabrecta (capmatinib) as a monotherapy for the treatment of adults with advanced non-small cell lung cancer (NSCLC)…
Read More...

Radius Health, Inc. announced that it has entered into a definitive agreement to be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately…
Read More...

Novavax, Inc. announced that the Taiwan Food and Drug Administration has granted emergency use authorization (EUA) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in individuals aged 18…
Read More...

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model,…
Read More...

Johnson & Johnson (the Company) announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) at Singapore’s Duke-NUS Medical School,…
Read More...

Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global healthcare company, announced a partnership to advance early diagnosis of…
Read More...

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that the U.S. Food and Drug…
Read More...

Galapagos NV, CellPoint and AboundBio announced that both companies have entered into definitive agreements with Galapagos, propelling Galapagos into next-generation cell therapy while …
Read More...